DEFB103A

Chr 8

defensin beta 103A

Also known as: BD-3, DEFB-3, DEFB103, DEFB3, HBD3, HBP-3, HBP3

Defensins form a family of microbicidal and cytotoxic peptides made by neutrophils. Members of the defensin family are highly similar in protein sequence. This gene encodes defensin, beta 103, an antibiotic peptide which is induced by bacteria and interferon gamma, and which displays antimicrobial activity against S. aureus, S. pyogenes, P. aeruginosa, E. coli, and C. albicans. [provided by RefSeq, Oct 2014]

0
Active trials
89
Pathogenic / LP
197
ClinVar variants
3
Pubs (1 yr)
Missense Z
LOEUF
Clinical SummaryDEFB103A
📋
ClinVar Variants
89 Pathogenic / Likely Pathogenic· 3 VUS of 197 total submissions

Population Genetics & Constraint

Constraint data not available from gnomAD.

ClinVar Variant Classifications

197 submitted variants in ClinVar

Classification Summary

Pathogenic86
Likely Pathogenic3
VUS3
Benign104
Conflicting1
86
Pathogenic
3
Likely Pathogenic
3
VUS
104
Benign
1
Conflicting

Curated Variants Distribution

Classified variants from ClinVar · 5 ACMG categories· variant type breakdown unavailable

ClassificationLoFMissense + InframeNon-codingSynonymousTotal
Pathogenic
86
Likely Pathogenic
3
VUS
3
Likely Benign
0
Benign
104
Conflicting
1
Total197

Counts from ClinVar esearch · Updated hourly

View in ClinVar →

DEFB103A · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →
Clinical Literature
Landmark / reviewRecent case evidence
Recent Gene-Specific Literature
Gene in title · MEDLINE · newest first
Europe PMC

No open access results found